160 related articles for article (PubMed ID: 15766304)
1. Preliminary observations on the effectiveness of levetiracetam in the open adjunctive treatment of refractory bipolar disorder.
Post RM; Altshuler LL; Frye MA; Suppes T; McElroy SL; Keck PE; Leverich GS; Kupka R; Nolen WA; Luckenbaugh DA; Walden J; Grunze H
J Clin Psychiatry; 2005 Mar; 66(3):370-4. PubMed ID: 15766304
[TBL] [Abstract][Full Text] [Related]
2. Open-label adjunctive zonisamide in the treatment of bipolar disorders: a prospective trial.
McElroy SL; Suppes T; Keck PE; Black D; Frye MA; Altshuler LL; Nolen WA; Kupka RW; Leverich GS; Walden J; Grunze H; Post RM
J Clin Psychiatry; 2005 May; 66(5):617-24. PubMed ID: 15889949
[TBL] [Abstract][Full Text] [Related]
3. Levetiracetam for treatment-refractory posttraumatic stress disorder.
Kinrys G; Wygant LE; Pardo TB; Melo M
J Clin Psychiatry; 2006 Feb; 67(2):211-4. PubMed ID: 16566615
[TBL] [Abstract][Full Text] [Related]
4. An open-label study of levetiracetam for the treatment of social anxiety disorder.
Simon NM; Worthington JJ; Doyle AC; Hoge EA; Kinrys G; Fischmann D; Link N; Pollack MH
J Clin Psychiatry; 2004 Sep; 65(9):1219-22. PubMed ID: 15367048
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of risperidone in the treatment of schizoaffective disorder: initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD).
Vieta E; Herraiz M; Fernández A; Gastó C; Benabarre A; Colom F; Martínez-Arán A; Reinares M
J Clin Psychiatry; 2001 Aug; 62(8):623-30. PubMed ID: 11561935
[TBL] [Abstract][Full Text] [Related]
6. Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study.
Sanger TM; Grundy SL; Gibson PJ; Namjoshi MA; Greaney MG; Tohen MF
J Clin Psychiatry; 2001 Apr; 62(4):273-81. PubMed ID: 11379842
[TBL] [Abstract][Full Text] [Related]
7. Levetiracetam in the treatment of acute mania: an open add-on study with an on-off-on design.
Grunze H; Langosch J; Born C; Schaub G; Walden J
J Clin Psychiatry; 2003 Jul; 64(7):781-4. PubMed ID: 12934978
[TBL] [Abstract][Full Text] [Related]
8. Risperidone in combination with mood stabilizers: a 10-week continuation phase study in bipolar I disorder.
Bowden CL; Myers JE; Grossman F; Xie Y
J Clin Psychiatry; 2004 May; 65(5):707-14. PubMed ID: 15163260
[TBL] [Abstract][Full Text] [Related]
9. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA
J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
[TBL] [Abstract][Full Text] [Related]
10. Levetiracetam in the management of bipolar depression: a randomized, double-blind, placebo-controlled trial.
Saricicek A; Maloney K; Muralidharan A; Ruf B; Blumberg HP; Sanacora G; Lorberg B; Pittman B; Bhagwagar Z
J Clin Psychiatry; 2011 Jun; 72(6):744-50. PubMed ID: 21034692
[TBL] [Abstract][Full Text] [Related]
11. Levetiracetam as adjunctive therapy for refractory anxiety disorders.
Kinrys G; Worthington JJ; Wygant L; Nery F; Reese H; Pollack MH
J Clin Psychiatry; 2007 Jul; 68(7):1010-3. PubMed ID: 17685735
[TBL] [Abstract][Full Text] [Related]
12. Risperidone in the treatment of mixed state bipolar patients: results from a 24-week, multicenter, open-label study in Korea.
Woo YS; Bahk WM; Jon DI; Chung SK; Lee SY; Ahn YM; Pae CU; Cho HS; Kim JG; Hwang TY; Lee HS; Min KJ; Lee KU; Yoon BH
Psychiatry Clin Neurosci; 2010 Feb; 64(1):28-37. PubMed ID: 19895394
[TBL] [Abstract][Full Text] [Related]
13. Monotherapy treatment of bipolar disorder with levetiracetam.
Kaufman KR
Epilepsy Behav; 2004 Dec; 5(6):1017-20. PubMed ID: 15582854
[TBL] [Abstract][Full Text] [Related]
14. The use of levetiracetam to decrease mania in elderly bipolar patients.
Kyomen HH
Am J Geriatr Psychiatry; 2006 Nov; 14(11):985. PubMed ID: 17068322
[No Abstract] [Full Text] [Related]
15. Safety and efficacy of levetiracetam for patients with panic disorder: results of an open-label, fixed-flexible dose study.
Papp LA
J Clin Psychiatry; 2006 Oct; 67(10):1573-6. PubMed ID: 17107249
[TBL] [Abstract][Full Text] [Related]
16. Levetiracetam as monotherapy or add-on to valproate in the treatment of acute mania-a randomized open-label study.
Krüger S; Sarkar R; Pietsch R; Hasenclever D; Bräunig P
Psychopharmacology (Berl); 2008 Jun; 198(2):297-9. PubMed ID: 18369598
[No Abstract] [Full Text] [Related]
17. Placebo-controlled study of quetiapine monotherapy in ambulatory bipolar spectrum disorder with moderate-to-severe hypomania or mild mania.
McElroy SL; Martens BE; Winstanley EL; Creech R; Malhotra S; Keck PE
J Affect Disord; 2010 Jul; 124(1-2):157-63. PubMed ID: 19963274
[TBL] [Abstract][Full Text] [Related]
18. Antimanic efficacy of topiramate in 11 patients in an open trial with an on-off-on design.
Grunze HC; Normann C; Langosch J; Schaefer M; Amann B; Sterr A; Schloesser S; Kleindienst N; Walden J
J Clin Psychiatry; 2001 Jun; 62(6):464-8. PubMed ID: 11465524
[TBL] [Abstract][Full Text] [Related]
19. A 52-week, open-label continuation study of lamotrigine in the treatment of bipolar depression.
McElroy SL; Zarate CA; Cookson J; Suppes T; Huffman RF; Greene P; Ascher J
J Clin Psychiatry; 2004 Feb; 65(2):204-10. PubMed ID: 15003074
[TBL] [Abstract][Full Text] [Related]
20. Potential of levetiracetam in mood disorders: a preliminary review.
Muralidharan A; Bhagwagar Z
CNS Drugs; 2006; 20(12):969-79. PubMed ID: 17140277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
